Incyte Corp. sell BMO Capital Markets
Start price
30.07.25
/
50%
€67.88
Target price
30.07.26
€51.87
Performance (%)
26.25%
Price
27.02.26
€85.70
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 26.25%. This prediction currently runs until 30.07.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Incyte Corp. | -0.349% | -0.349% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Corporation (NASDAQ: INCY) had its price target raised by analysts at BMO Capital Markets from $52.00 to $60.00. They now have an "underperform" rating on the stock.
Ratings data for INCY provided by MarketBeat